YELLON, Derek M
Patients were excluded if they had a major cardiovascular event within the last 60 days, type 1 diabetes mellitus, history of pancreatitis, or a history of severe hypoglycemia
Later in 2022, the FDA granted tirzepetide fast track designation for overweight and obesity in adults.6 To date, tirzepetide hasnt been FDA approved for weight loss (see table Current FDA-Approved Mono and Dual Agonists for details about weight management medications)
The guide on selecting the right water for peptide mixing explains why bacteriostatic water is preferred over sterile water for multi-dose vials and how the preservative in bacteriostatic water protects against contamination during repeated needle punctures
NICE has approved semaglutide 2.4 mg (Wegovy) for use within specialist weight management services (NICE TA875), subject to specific eligibility criteria including a BMI of 35 kg/m or above (or 32.5 kg/m or above in people from certain ethnic minority backgrounds at higher metabolic risk) alongside at least one weight-related comorbidity
Many compounded formulations include B12 , glycine , or niacinamide to offset this effect and improve tolerability